Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Efficacy and Safety of Y-3 Intracalvariosseous Injection Bypassing Blood-brain Barrier Versus Intravenous Injection in the Treatment of Acute Large Hemispheric Infarction（SOLUTION-2）

NCT06374667 is registered in ClinicalTrials.gov with yilong Wang as lead sponsor.

NCT NCT06374667
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06374667 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Efficacy and Safety of Y-3 Intracalvariosseous Injection Bypassing Blood-brain Barrier Versus Intravenous Injection in the Treatment of Acute Large Hemispheric Infarction（SOLUTION-2）
Lead sponsor
yilong Wang
Phase
Not applicable
Overall status
Recruiting
Start date
April 22, 2024
Completion date
March 15, 2027
Enrollment
134 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

blood-brain barrier, stroke, acute ischemic